POWER Study (Prospective Transbronchial Microwave + Robotic-Assisted Bronchoscopy)

INCLUSION CRITERIA: * Signed informed consent. * Subjects greater or equal to 22 years old. * Performance status 0-2 (Eastern Cooperative Oncology Group classification (ECOG). * Willing to fulfill all follow-up visit requirements. * Subjects with at least one oligometastatic lung tumor where the primary tumor is controlled (in the opinion of the investigator or treating oncologist). * Oligometastatic lung tumor(s) planned to be ablated in the outer two-thirds of the lung and not closer than 1cm to the pleura. EXCLUSION CRITERIA: * Pregnant or breastfeeding. * Subjects with thoracic implantable devices, including pacemakers or other electronic implants. * Chronic, continuous ventilator support, which uses bi-level positive airway pressure (PAP) to improve lung function for severe conditions. (However, intermittent PAP, for non-pulmonary conditions, such as sleep apnea, is permitted). * Prior pneumonectomy. * Severe bronchiectasis (with FEV1 \<30%) or disease deemed to be too severe in the opinion of the investigator. * Platelet count ≤ 50,000/mm3. * Subjects with uncorrectable coagulopathy at time of screening. * Subjects medically unable to stop anti-platelet agents (e.g., aspirin, clopidogrel, prasugrel, ticagrelor) at least 5 days prior to the procedure through 48-72 hours after the procedure. * Subjects medically unable to stop warfarin at least 3-5 days prior to the ablation procedure, or until INR \< 1.5, through 48-72 hours after the procedure. On the day of the proc…